Chulyong Kim

Chulyong Kim

Auto-generated profile, based on publicly available information

Chulyong Kim

Woodruff School of Mechanical Engineering, Georgia Institute of Technology, Atlanta, Georgia, USA (C.K., C.A.)

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 July 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
AAAshley Alva
Ashley Alva
CKChulyong Kim
Chulyong Kim
PPPranav Premdas
Pranav Premdas
YFYann Ferry
Yann Ferry
HLHohyun Lee
Hohyun Lee
CACostas Arvanitis
Costas Arvanitis
Imaging macrophage trafficking in solid tumors has major implications for cancer diagnosis, prognosis, and therapy. Here, we show that macrophage labeling with lipid-shelled microbubbles enables ultrasound imaging at single-cell level. Crucially, microbubble labeling and sonication at low mechanical indexes do not affect macrophage viability, migration, phenotype, and cytokine secretion profile, supporting the notion that ultrasound imaging can be used for nondestructive macrophage imaging. Despite the damping exerted on the microbubble oscillations by the cellular compartments, the microbubbles exhibit highly nonlinear behavior upon sonication, allowing for high specificity nonlinear US imaging under in vitro and in vivo conditions. Subsequently, we demonstrate that nonlinear ultrasound imaging can selectively monitor macrophage accumulation and extravasation in solid tumors in rodents for at least 8 h after intravenous administration. These findings establish ultrasound as a noninvasive platform for immune cell trafficking in solid tumors and highlight its potential to advance cancer diagnosis, monitoring, and therapy.

26 April 2025 in bioRxiv
Verified
Preprint
Open access
AZAli Zamat
Ali Zamat
CKChulyong Kim
Chulyong Kim
SSShwetha Sridhar
Shwetha Sridhar
SFSydney Fabrega
Sydney Fabrega
RSRiya Sen
Riya Sen
GKGabriel A. Kwong
Gabriel A. Kwong
Achieving durable CAR T cell responses against primary brain tumors and metastases requires strategies that enable intracranial control of therapy to overcome the barriers of solid tumor treatment without compromising safety. Here, we show that closed-loop sonothermogenetics enables remote regulation of CAR T cell therapeutic activity through the intact skull. Using MR-guided focused ultrasound with closed-loop temperature feedback, we modulate CAR T cells engineered with a genetically encoded thermal bioswitch to achieve metronomic activation in the brain without lasting adverse effects on healthy brain tissue. In murine models of brain cancer, metronomic production of NKG2D T cell engagers by intratumoral CAR T cells overcomes antigen heterogeneity in breast cancer brain metastasis and myeloid-derived immunosuppression in glioblastoma to drive antitumor responses. Our findings support the use of closed-loop sonothermogenetics for spatial and temporal control of CAR T cell therapies targeting solid brain tumors.

3 April 2026 in Neuro-Oncology
Verified
Journal Article
Closed access
ZTZhuoqi Tong
Zhuoqi Tong
CKChulyong Kim
Chulyong Kim
JRJames L Ross
James L Ross
CACostas Arvanitis
Costas Arvanitis
For peripheral immune cells to be effective against brain tumors, multiple coordinated steps are required, including migration and homing to the local microenvironment—collectively referred to as immune cell trafficking—followed by survival, proliferation, and persistence, all while remaining functional. This review focuses on the often-overlooked first step, trafficking, which is critical for initiating subsequent processes and driving antitumor responses. We summarize the migration cascade of immune cells, including T cells and macrophages, across the blood-brain barrier (BBB) and how primary brain tumors as well as brain metastases alter the molecular pathways and interactions associated with the immune cell migration cascade across the BBB and their functional homing. Subsequently, we highlight recent developments in engineering biomolecular, cellular, and physical methods to modulate the tumor microenvironment and improve the functional trafficking of immune cells in brain tumors. Our analysis reveals novel combinations to potentiate antitumor responses via feedforward mechanisms and modular therapeutic strategies designed to improve the migration and accumulation of functional immune cells in brain tumors. A deeper understanding of immune cell trafficking, distribution, and homing through the application of preclinical and clinical imaging techniques along with the development of in vitro/ex vivo platforms should enable new and more potent immunotherapy strategies against primary brain malignancies and brain metastases as well as accelerate their translation to the clinic.

7 January 2026 in Advanced Science
Verified
Journal Article
Open access
HLHohyun Lee
Hohyun Lee
VMVictor Menezes
Victor Menezes
SZShiqin Zeng
Shiqin Zeng
CKChulyong Kim
Chulyong Kim
CBCynthia M. Baseman
Cynthia M. Baseman
CACostas Arvanitis
Costas Arvanitis
The blood‐brain barrier (BBB) renders the delivery of nanomedicine in the brain ineffective and the detection of circulating disease‐related DNA from the brain unreliable. Here, we demonstrate that microbubble‐enhanced focused ultrasound (MB‐FUS) mediated BBB opening, supported by large‐data models predict sonication regimens for safe and effective BBB opening. Importantly, a closed‐loop MB‐FUS controller augmented by machine learning (ML‐CL) expands the treatment window, as compared to conventional controllers, by persistently and proactively maximizing the BBB permeability while preventing tissue damage. By successfully scaling up from mice to rats and from healthy to diseased brains (glioma), ML‐CL rendered the BBB permeable to large nanoparticles and markedly improved the release and detection of reporter gene DNA from tumors in blood. Together, our findings reveal the potential of data‐driven feedback to support the development of next‐generation AI‐powered ultrasound systems for safe, robust, and efficient nanotheranostic targeting and treatment of brain diseases.

1 April 2021 in The Journal of the Acoustical Society of America
Verified
Journal Article
Closed access
PDF file
CACostas Arvanitis
Costas Arvanitis
CKChulyong Kim
Chulyong Kim
YGYutong Guo
Yutong Guo
AVAnastasia Velalopoulou
Anastasia Velalopoulou
We hypothesized that localized thermal stress could change the cerebrovascular transport dynamics in the brain tumor micro-environment. Our findings, using a closed-loop trans-cranial MR guided FUS system, support our hypothesis and provide evidence that spatially controlled thermal stress can enable the development of therapeutic strategies to reduce systemic toxicity while attaining high drug accumulation to the tumor core.

7 May 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
HLHohyun Lee
Hohyun Lee
VMVictor Menezes
Victor Menezes
SZShiqin Zeng
Shiqin Zeng
CKChulyong Kim
Chulyong Kim
CBCynthia M. Baseman
Cynthia M. Baseman
CACostas Arvanitis
Costas Arvanitis
The blood-brain barrier (BBB) renders the delivery of nanomedicine in the brain ineffective and the detection of circulating disease-related DNA from the brain unreliable. Here, we show that the acoustic emission content of focused ultrasound-controlled microbubble dynamics (MB-FUS) incorporates precursor signals that allow large-data models to predict sonication regimens for safe and effective BBB opening. Crucially, closed-loop MB-FUS controller augmented by machine learning (ML-CL) expands the treatment window (4-fold), as compared to conventional controllers, by persistently and proactively maximizing the BBB permeability while preventing tissue damage. By successfully scaling up from mice to rats and from healthy to diseased brains (glioma), ML-CL rendered the BBB permeable to large nanoparticles and markedly improved the release and detection of tumor DNA in plasma. Together, our findings reveal the potential of data-driven feedback to support the development of next-generation AI-powered ultrasound systems for safe, robust, and efficient nanotheranostic targeting of brain diseases.